par Aude | Jan 21, 2026 | Non classé
Aanastra Inc and Divincell SAS will be presenting “the PEP-NP : Peptide-based Nanoparticle platform for Targeted delivery functional mRNAs and in vivo CAR-T generation” at the 5th mRNA Based Therapeutics Summit Europe in Berlin. January 28-30,...
par Aude | Oct 15, 2025 | Non classé
Aanastra Inc and Divincell to highlight its technology in Multiple Presentations at the Advancing Gene and Cell Therapies for Cancer Conference, Philadelphia. October 15-16, 2025
par Aude | Oct 14, 2025 | Non classé
Aanastra Inc and Divincell Announce Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 Mutations in Tumors (AAN-53x). October 14, 2025
par Aude | Juin 26, 2025 | Non classé
Aanastra Inc/DIVINCELL present their” Peptide-based Nanoparticle platform for Extrahepatic Targeted delivery of Functional mRNAs “ at the 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit in Boston, June 26-28th, 2025. https://ter.li/u0m95x
par Aude | Juin 25, 2025 | Non classé
Aanastra Inc/DIVINCELL present Peptide-based Nanoparticle platform for Targeted delivery at the 2nd Peptide Formulation & Delivery Innovation Summit in Boston, June 25-26th, 2025.https://ter.li/xoov9x
